Pfizer
Erika Bean is an experienced marketing professional currently working at Pfizer since May 2008, where roles have included U.S. PAXLOVID Market Shaping & Competitive Strategy, Customer-Facing and Channel Strategy Lead, and Marketing Director for Hospital & Acute Care Strategy. Prior positions at Pfizer also include Senior Manager Marketing for the U.S. Women's Health Portfolio and Institutional Sales Account Manager for the West Region, focusing on managing Southern Arizona hospitals and specialties such as oncology and cardiology. In addition to Pfizer, Erika Bean serves as a U.S. Women’s ADV Team Member for REV'IT! Sport International since January 2016. Erika Bean holds degrees in Cancer Biology and Molecular and Cellular Biology from the University of Arizona.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.